Veracyte (VCYT) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Veracyte (VCYT) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 3.80% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -91.18% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 120.45% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.61% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 97.40% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -28.45% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -11.26% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.67% |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | 176.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176.73% |
| Mar 31, 2026 | 700.66% |
| Dec 31, 2025 | 802.76% |
| Sep 30, 2025 | -68.87% |
| Jun 30, 2025 | -115.04% |
| Mar 31, 2025 | 163.10% |
| Dec 31, 2024 | 109.02% |
| Sep 30, 2024 | 145.11% |
| Jun 30, 2024 | 183.39% |
| Mar 31, 2024 | 35.30% |
| Dec 31, 2023 | -1,604.64% |
| Sep 30, 2023 | -304.63% |
| Jun 30, 2023 | 23.17% |
| Mar 31, 2023 | 26.92% |
| Sep 30, 2022 | 29.71% |
| Jun 30, 2022 | -13.89% |
| Mar 31, 2022 | 74.43% |
| Sep 30, 2021 | 88.89% |
| Jun 30, 2021 | 97.25% |
| Mar 31, 2021 | 84.44% |